Back to results
US 2025/0082647 A1Published application
Specific dosage of phenothiazine compounds for use in treatment or prevention of alzheimer's dementia
AssigneeImmungenetics AG
InventorMarkus KROHN
Life of this patent
Estimating the term…
Abstract
The present invention relates in a first aspect to a compound of formula (I) for use in the treatment and/or in prevention of Alzheimer's dementia, wherein the compound of formula (I) is administered in a dosage<20 mg. In a second aspect, the invention relates to a pharmaceutical composition comprising the compound according to the first aspect.
Claims21
1-10. (canceled)
A method for treating and/or preventing Alzheimer's dementia in a subject, wherein the method comprises:
- administering a compound of formula (I);
- wherein:
- R1 is selected from the group consisting of hydrogen atom, halogen atom, methoxy group, perhalogenated alkyl group and —X-C1 to C2 alkyl group, wherein X is either a sulphur atom or an oxygen atom;
- R2 is a hydrogen atom or a methyl group;
- R3, R4 are independently of each other either a hydrogen atom or C1 to C4 alkyl group or form together a six membered alkyl ring which comprises at least one further nitrogen atom, wherein the at least one further nitrogen is substituted with a C1 to C3 alkyl-R5 group, wherein R5 is a hydrogen atom or a hydroxyl group;
- n is zero or 1;
- m is zero or an integer selected from the range of from 1 to 4;
- p is zero or an integer selected from the range of from 1 to 3;
- wherein the compound of formula (I) is administered in a dosage≤20 mg per day of administration.
6 more elements
Dependencies are inferred from the claim text.